Skip to content
Grazia British
FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

FDA announces plan for folinic acid to be accessible prescription treatment for children with autism

By Swedan Margen

Culture

Food and Drug Administration Commissioner Dr. Martin A. Makary announced that the FDA is filing a federal register notice to change the label on Leucovorin, so it can be prescribed to treat children with autism.

Originally published by washingtontimes.com. Syndicated material does not necessarily reflect the views of Grazia British.

More Culture

FDA announces plan for folinic acid to be accessible prescription treatment for children with autism | Grazia British